Metabolic effects of galanin injections into the paraventricular nucleus of the hypothalamus.
The metabolic effects of single injections of galanin into the paraventricular nucleus of the hypothalamus (PVN) were investigated in an open-circuit calorimeter. Wistar rats were tested, with no food available during the tests. In the dose range of 0.03-0.3 nmol, galanin produced a very short-latency (approximately 2 minutes) and short-lasting (approximately 15 minutes) reduction in energy expenditure. Since the same doses had no effect on respiratory quotient or locomotor activity, the metabolic effect is not secondary to changes in energy substrate utilization or locomotor activity. This antithermogenic effect complements the eating stimulatory action of PVN galanin, and together these phenomena suggest a role for galanin as an anabolic neuropeptide. The similarity of galanin's effects to those of norepinephrine, with which it coexists in PVN nerve endings, further suggests the involvement of this amine and the PVN alpha2-noradrenergic system in galanin's mechanism of action.
Menéndez
J A
JA
Department of Psychology, University of Sydney, NSW, Australia.
Atrens
D M
DM
Leibowitz
S F
SF
D000818:Animals; D004734:Energy Metabolism / Q000187:drug effects*; D019004:Galanin; D008845:Microinjections; D009043:Motor Activity / Q000187:drug effects; D009479:Neuropeptides / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D009479:Neuropeptides; D010455:Peptides; D019004:Galanin